Eshin K

No ORCID on file · 3 papers in corpus
2026
International journal of transgender health ·doi:10.1080/26895269.2024.2403140

BackgroundThe cessation of menstruation is a common and desired outcome of testosterone gender-affirming hormone therapy (GAHT), for trans and gender diverse (collectively referred to as trans) individuals recorded female at birth. This stu…

other 2023
LGBT health ·doi:10.1089/lgbt.2022.0187

Purpose: This descriptive study aimed to assess the characteristics of pelvic pain and explore predictive factors for pelvic pain in transgender (trans) individuals using testosterone therapy. Methods: An online cross-sectional survey was o…

preprint 2022
·doi:10.22541/au.165388691.10496458/v1

Objective: This descriptive study aimed to assess the prevalence and characteristics of pelvic pain and explore predictive factors for pelvic pain in transgender (trans) individuals using testosterone therapy. Design: Cross-sectional survey…